Thanks for clarifying Suzuki. I believe that’s the heart of the debate on this forum at the moment. We have 2 camps here:-
(1) True Believers (and I’m in this camp) believe that BSI is undertaking a thorough internal review and the process is slow but ultimately, Oncosil will prevail.
(2) The Naysayers/Doomsdayers believe that BSI will not approve and reject CE Mark based on doubts, concerns or uncertainties over the merit/efficacy/safety of the Oncosil device. Hence, Oncosil will not prevail.
This, in a nutshell is the crux of the debate between the 2 camps.
GW
OSL Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)